Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens Used in Japan: A Systematic Review and Network Meta-analysis

IMPORTANCE: Various first-line chemotherapy treatment regimens for patients with metastatic pancreatic cancer have been approved in Japan, including gemcitabine (GEM); fluorouracil, leucovorin, irinotecan, and oxaliplatin combination (FOLFIRINOX); GEM plus albumin-bound paclitaxel (GEM+NPTX), and S-...

Descripción completa

Detalles Bibliográficos
Autores principales: Takumoto, Yuki, Sasahara, Yuriko, Narimatsu, Hiroto, Akazawa, Manabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804927/
https://www.ncbi.nlm.nih.gov/pubmed/35099549
http://dx.doi.org/10.1001/jamanetworkopen.2021.45515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804927/
https://www.ncbi.nlm.nih.gov/pubmed/35099549
http://dx.doi.org/10.1001/jamanetworkopen.2021.45515

Ejemplares similares